Biomarkers for Early-Stage Breast Cancer: Clinical Utility for Extended Adjuvant Treatment Decisions

被引：1
|
作者：
Sgroi, Dennis C. [1 ,2 ]
Brufsky, Adam [3 ]
机构：
[1] Massachusetts Gen Hosp, Charlestown, MA 02129 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 32期
关键词：
LATE-DISTANT RECURRENCE; PRACTICE GUIDELINE; AMERICAN SOCIETY; RANDOMIZED-TRIAL; THERAPY; TAMOXIFEN; WOMEN;
D O I：
10.1200/JCO.2016.67.2949
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3941 / +
页数：3
相关论文
共 50 条
  • [21] Adjuvant Hormonal Therapy for Early-Stage Breast Cancer
    Burstein, Harold J.
    Griggs, Jennifer J.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (03) : 639 - +
  • [22] Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary
    Harris, Lyndsay N.
    Ismaila, Nofisat
    McShane, Lisa M.
    Hayes, Daniel F.
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (04) : 384 - +
  • [23] Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
    Jansen, SJT
    Kievit, J
    Nooij, MA
    de Haes, JCJM
    Overpelt, IME
    van Slooten, H
    Maartense, E
    Stiggelbout, AM
    BRITISH JOURNAL OF CANCER, 2001, 84 (12) : 1577 - 1585
  • [24] Patients’ preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
    S J T Jansen
    J Kievit
    M A Nooij
    J C J M de Haes
    I M E Overpelt
    H van Slooten
    E Maartense
    A M Stiggelbout
    British Journal of Cancer, 2001, 84 : 1577 - 1585
  • [25] Epigenetic and genetic biomarkers, of early-stage breast cancer
    Jarmalaite, Sonata
    Laurinaviciene, Aida
    Dimonaite, Justina
    Scesnaite, Asta
    Dasevicius, Darius
    Ostapenko, Velerijus
    Lazutka, Juozas
    CELLULAR ONCOLOGY, 2008, 30 (03) : 259 - 260
  • [26] Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial
    Asleh, Karama
    Brauer, Heather Ann
    Sullivan, Amy
    Lauttia, Susanna
    Lindman, Henrik
    Nielsen, Torsten O.
    Joensuu, Heikki
    Thompson, E. Aubrey
    Chumsri, Saranya
    CLINICAL CANCER RESEARCH, 2020, 26 (11) : 2603 - 2614
  • [27] Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update Q and A
    Raab, Rachel
    Ismaila, Nofisat
    Andre, Fabrice
    Stearns, Vered
    Kalinsky, Kevin
    JCO ONCOLOGY PRACTICE, 2022, 18 (09) : 646 - +
  • [28] CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR plus Breast Cancer Patients: Indian Scenario
    Sankaran, Satish
    Dikshit, Jyoti Bajpai
    Sv, Chandra Prakash
    Mallikarjuna, Se
    Somashekhar, Sp
    Patil, Shekhar
    Kumar, Rajeev
    Prasad, Krishna
    Shet, Dinesh
    Bakre, Manjiri M.
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2021, 12 (SUPPL 1) : 21 - 29
  • [29] CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario
    Satish Sankaran
    Jyoti Bajpai Dikshit
    Chandra Prakash SV
    SE Mallikarjuna
    SP Somashekhar
    Shekhar Patil
    Rajeev Kumar
    Krishna Prasad
    Dinesh Shet
    Manjiri M. Bakre
    Indian Journal of Surgical Oncology, 2021, 12 : 21 - 29
  • [30] Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
    Krop, Ian
    Ismaila, Nofisat
    Andre, Fabrice
    Bast, Robert C.
    Barlow, William
    Collyar, Deborah E.
    Hammond, M. Elizabeth
    Kuderer, Nicole M.
    Liu, Minetta C.
    Mennel, Robert G.
    Van Poznak, Catherine
    Wolff, Antonio C.
    Stearns, Vered
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (24) : 2838 - +
12345